Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1170894
PUBLISHER: Grand View Research | PRODUCT CODE: 1170894
Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2022 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Smart Inhalers Market Growth & Trends:
The global smart inhalers market size is expected to reach USD 53.3 billion by 2030, based on a new report by Grand View Research, Inc., expanding at a CAGR of 19.3% from 2022 to 2030. The rising prevalence of chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and lung disorders is contributing to the growth of the market. According to the European Respiratory Society Congress, COPD is expected to affect over 480 million people in 2022 across the globe.
COVID-19 has increased the demand for smart inhalers due to the rising penetration of cutting-edge digital devices and solutions for respiratory and pulmonary care. Furthermore, in the post-pandemic era, it is expected that the adoption of smart inhalers will increase as healthcare providers are focusing on connected medical devices to ensure that patients receive better and more enhanced care, regardless of the circumstance.
Furthermore, a growing number of businesses are incorporating digital technologies into their products to improve the efficiency of medication and the management of asthma and COPD. In addition, in April 2022, Aptar Pharma, a key market player, introduced HeroTracker Sense, a novel digital chronic respiratory e-health solution that converts a traditional metered dose inhaler into a smart inhaler. Furthermore, a study of the Adherium Smart inhaler also revealed that smart inhaler users experienced several beneficial medical outcomes, including fewer hospitalizations, improved medication adherence, and a decreased need for doctor visits.
Smart Inhalers Market Report Highlights:
- Based on type, the metered dose inhalers (MDIs) segment held the largest share of over 60.0% in 2021. MDIs are the most preferred inhalers used to treat CRDs. The dry powdered inhalers (DPIs) segment is expected to register the fastest growth rate of 18.6% over the forecast period owing to the convenience of its mechanism, which makes it easier to use for medicine delivery
- Based on indication, the COPD segment held the largest share of over 50.0% in 2021 due to the high prevalence of COPD as it affects 200 million people globally. The asthma segment is anticipated to grow at the fastest rate of 18.3% over the forecast period owing to the rising number of hospitalizations for asthma, particularly in young children
- Based on distribution channel, the hospital pharmacies segment held the largest share of over 40.0% in 2021. The elderly population frequently receives hospital care for CRDs, and they consider purchasing medication from hospital pharmacies. The retail pharmacies segment is anticipated to grow at a rate of 19.2% over the forecast period due to the quick expansion and modernization of the existing pharmacies to increase market penetration
- Based on end-use, the hospitals segment accounted for the largest share of over 50.0% in 2021 as hospitals are a crucial distribution channel between pharmaceutical companies and patients. The home care settings segment is anticipated to grow at the fastest rate of 20.2% over the forecast period due to the growing preference among older patients, rising costs of healthcare, and the convenience offered by the treatments at home
- In 2021, North America dominated the market with a share of over 45.0% owing to the rising prevalence of CRDs in the region. In the U.S., more than 25 million people suffer from asthma. Asia Pacific is expected to expand at the fastest rate of 21.2% during the forecast period owing to rising incidence rates of COPD and asthma in developing nations such as China and India
Product Code: GVR-4-68039-993-1
Table of Contents
Chapter 1 Report Scope and Objectives
- 1.1 Market Segmentation & Scope
- 1.2 Regional Scope
- 1.2.1 Estimates And Forecast Timeline
- 1.3 Objectives
- 1.3.1 Objective - 1
- 1.3.2 Objective - 2
- 1.3.3 Objective - 3
Chapter 2 Methodology
- 2.1 Research Methodology
- 2.2 Information Procurement
- 2.2.1 Purchased Database
- 2.2.2 Gvr's Internal Database
- 2.2.3 Secondary Sources
- 2.2.4 Primary Research
- 2.3 Information or Data Analysis
- 2.3.1 Data Analysis Models
- 2.4 Market Formulation & Validation
- 2.5 Model Details
- 2.5.1 Commodity Flow Analysis (Model 1)
- 2.5.2 Volume Price Analysis (Model 2)
- 2.6 List of Secondary Sources
Chapter 3 Executive Summary
- 3.1 Market Outlook
- 3.2 Segment Outlook
- 3.2.1 type
- 3.2.2 Indication
- 3.2.3 distribution Channel
- 3.2.4 end-Use
- 3.2.5 Region
- 3.3 Competitive Insights
- 3.4 Smart Inhalers Market Outlook, 2021
Chapter 4 Market Variables, Trends & Scope
- 4.1 Market Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.1.2 Ancillary Market Outlook
- 4.2 Smart Inhalers Market Dynamics
- 4.2.1 Market Driver Analysis
- 4.2.2 Market Restraint Analysis
- 4.3 Smart Inhalers Market: Business Environment Analysis Tools
- 4.3.1 Porter's Five Forces Analysis
- 4.3.1.1 Threat Of New Entrants
- 4.3.1.2 Bargaining Power Of Suppliers
- 4.3.1.3 Bargaining Power Of Buyers
- 4.3.1.4 Competitive Rivalry
- 4.3.1.5 Threat Of Substitutes
- 4.3.2 Pestel Analysis
- 4.3.2.1 Political & Legal
- 4.3.2.2 Economic & social
- 4.3.2.3 Technological
- 4.3.2.4 Environmental
- 4.3.1 Porter's Five Forces Analysis
- 4.4 Penetration & Growth Prospect Mapping
- 4.5 Technology Trend Analysis
- 4.6 Regulatory Framework
- 4.7 Impact of COVID-19 on Smart Inhalers Market
Chapter 5 Smart Inhalers Market: Type Analysis
- 5.1 Smart Inhalers Type Market Share Analysis, 2021 & 2030
- 5.2 Smart Inhalers Type Market: Segment Dashboard
- 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment
- 5.3.1 Dry Powdered Inhalers
- 5.3.1.1 Dry Powdered Inhalers (Dpis) Market, 2017 - 2030 (USD Million)
- 5.3.2 Metered Dose Inhalers
- 5.3.2.1 Metered dose inhalers (MDIs) market, 2017 - 2030 (USD Million)
- 5.3.1 Dry Powdered Inhalers
Chapter 6 Smart Inhalers Market: Indication Analysis
- 6.1 Smart Inhalers Indication Market Share Analysis, 2021 & 2030
- 6.2 Smart Inhalers Indication Market: Segment Dashboard
- 6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Indication Segment
- 6.3.1 Asthma3
- 6.3.1.1 Asthma Market, 2017 - 20302017 - 20302017 - 2030 (USD Million)
- 6.3.2 Copd
- 6.3.2.1 Copd Market, 2017 - 2030 (USD Million)
- 6.3.3 Others
- 6.3.3.1 Others market, 2017 - 2030 (USD Million)
- 6.3.1 Asthma3
Chapter 7 Smart Inhalers Market: Distribution Channel Analysis
- 7.1 Smart Inhalers Distribution Channel Market Share Analysis, 2021 & 2030
- 7.2 Smart Inhalers Distribution Channel Market: Segment Dashboard
- 7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Distribution Channel
- 7.3.1 Hospitals Pharmacies
- 7.3.1.1 Hospitals Pharmacies Market, 2017 - 2030 (USD Million)
- 7.3.2 Retail Pharmacies
- 7.3.2.1 Retail Pharmacies Market, 2017 - 2030 (USD Million)
- 7.3.3 Online Pharmacies
- 7.3.3.1 Online pharmacies market, 2017 - 2030 (USD Million)
- 7.3.1 Hospitals Pharmacies
Chapter 8 Smart Inhalers Market: End-Use Analysis
- 8.1 Smart Inhalers end-use Market Share Analysis, 2021 & 2030
- 8.2 Smart Inhalers End-Use Market: Segment Dashboard
- 8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment
- 8.3.1 Hospitals
- 8.3.1.1 Hospitals Market, 2017 - 2030 (USD Million)
- 8.3.2 Homcare Settings
- 8.3.2.1 Homecare Settings Market, 2017 - 2030 (USD Million)
- 8.3.3 Others
- 8.3.3.1 Others market, 2017 - 2030 (USD Million)
- 8.3.1 Hospitals
Chapter 9 Smart Inhalers Market: Regional Analysis
- 9.1 Smart Inhalers Regional Market Share Analysis, 2021 & 2030
- 9.2 Regional Market Snapshot
- 9.3 North America
- 9.3.1 North America Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.3.2 U.S.
- 9.3.2.1 U.S. Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.3.3 Canada
- 9.3.3.1 Canada Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.4 Europe
- 9.4.1 Europe Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.4.2 U.K.
- 9.4.2.1 U.K. Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.4.3 Germany
- 9.4.3.1 Germany Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.4.4 France
- 9.4.4.1 France smart inhalers market, 2017 - 2030 (USD Million)
- 9.4.5 Italy
- 9.4.5.1 Italy Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.4.6 Spain
- 9.4.6.1 Spain Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.4.7 Russia
- 9.4.7.1 Russia smart inhalers market, 2017 - 2030 (USD Million)
- 9.5 Asia Pacific
- 9.5.1 Asia Pacific Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.5.2 Japan
- 9.5.2.1 Japan Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.5.3 China
- 9.5.3.1 China Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.5.4 India
- 9.5.4.1 India Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.5.5 Australia
- 9.5.5.1 Australia Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.5.6 South Korea
- 9.5.6.1 South Korea Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.5.7 Singapore
- 9.5.7.1 Singapore Smart inhalers market, 2017 - 2030 (USD Million)
- 9.6 Latin America
- 9.6.1 Latin America Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.6.2 Brazil
- 9.6.2.1 Brazil Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.6.3 Mexico
- 9.6.3.1 Mexico Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.6.4 Argentina
- 9.6.4.1 Argentina Smart Inhalers market, 2017 - 2030 (USD Million)
- 9.7 Middle East and Africa (MEA)
- 9.7.1 MEA Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.7.2 South Africa
- 9.7.2.1 South Africa Smart Inhalers Market, 2017 - 2030 (USD Million)
- 9.7.3 Saudi Arbia
- 9.7.3.1 Saudi Arbia smart inhalers market, 2017 - 2030 (USD Million)
- 9.7.4 UAE
- 9.7.4.1 UAE smart inhalers market, 2017 - 2030 (USD Million)
Chapter 10 Competitive Analysis
- 10.1 Recent Developments & Impact Analysis, By Key Market Participants
- 10.2 Company Profiles
- 10.2.1 H&T PRESSPART MANUFACTURING LTD.
- 10.2.1.1 Company overview
- 10.2.1.2 Financial performance
- 10.2.1.3 Product benchmarking
- 10.2.1.4 Strategic initiatives
- 10.2.2 PERSONAL AIR QUALITY SYSTEMS PRIVATE LIMITED
- 10.2.2.1 Company overview
- 10.2.2.2 Financial performance
- 10.2.2.3 Product benchmarking
- 10.2.2.4 Strategic initiatives
- 10.2.3 COHERO HEALTH INC.
- 10.2.3.1 Company overview
- 10.2.3.2 Financial performance
- 10.2.3.3 Product benchmarking
- 10.2.3.4 Strategic initiatives
- 10.2.4 COGNITA LABS
- 10.2.2.1 Company overview
- 10.2.2.2 Financial performance
- 10.2.2.3 Product benchmarking
- 10.2.2.4 Strategic initiatives
- 10.2.4 ADHERIUM LIMITED
- 10.2.4.1 Company overview
- 10.2.4.2 Financial performance
- 10.2.4.3 Product benchmarking
- 10.2.4.4 Strategic initiatives
- 10.2.5 AMIKO DIGITAL HEALTH LIMITED
- 10.2.5.1 Company overview
- 10.2.5.2 Financial performance
- 10.2.5.3 Product benchmarking
- 10.2.5.4 Strategic initiatives
- 10.2.6 TEVA PHARMACEUTICALS INDUSTRIES LTD.
- 10.2.6.1 Company overview
- 10.2.6.2 Financial performance
- 10.2.6.3 Product benchmarking
- 10.2.6.4 Strategic initiatives
- 10.2.7 PROPELLER HEALTH
- 10.2.7.1 Company overview
- 10.2.7.2 Financial performance
- 10.2.7.3 Product benchmarking
- 10.2.7.4 Strategic initiatives
- 10.2.8 NOVARTIS AG
- 10.2.8.1 Company overview
- 10.2.8.2 Financial performance
- 10.2.8.3 Product benchmarking
- 10.2.8.4 Strategic initiatives
- 10.2.9 PNEUMA RESPIRATORY, INC.
- 10.2.9.1 Company overview
- 10.2.9.2 Financial performance
- 10.2.9.3 Product benchmarking
- 10.2.9.4 Strategic initiatives
- 10.2.10 3M HEALTH CARE LIMITED
- 10.2.10.1 Company overview
- 10.2.10.2 Financial performance
- 10.2.10.3 Product benchmarking
- 10.2.10.4 Strategic initiatives
- 10.2.11 FINDAIR SP. Z O.O.
- 10.2.11.1 Company overview
- 10.2.11.2 Financial performance
- 10.2.11.3 Product benchmarking
- 10.2.11.4 Strategic initiatives
- 10.2.12 AIREHEALTH, INC.
- 10.2.12.1 Company overview
- 10.2.12.2 Financial performance
- 10.2.12.3 Product benchmarking
- 10.2.12.4 Strategic initiatives
- 10.2.1 H&T PRESSPART MANUFACTURING LTD.
Product Code: GVR-4-68039-993-1
List of Tables
- Table 1 List of secondary sources
- Table 2 North America smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
- Table 3 North America smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 4 North America smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 5 North America smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 6 North America smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 7 U.S. smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 8 U.S. smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 9 U.S. smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 10 U.S. smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 11 Canada smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 12 Canada smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 13 Canada smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 14 Canada smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 15 Europe smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
- Table 16 Europe smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 17 Europe smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 18 Europe smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 19 Europe smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 20 U.K. smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 21 U.K. smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 22 U.K. smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 23 U.K. smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 24 Germany smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 25 Germany smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 26 Germany smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 27 Germany smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 28 France smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 29 France smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 30 France smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 31 France smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 32 Italy smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 33 Italy Smart Inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 34 Italy smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 35 Italy smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 36 Spain smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 37 Spain smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 38 Spain smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 39 Spain smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 40 Russia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 41Russia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 42 Russia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 43 Russia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 44 Asia Pacific smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
- Table 45 Asia Pacific smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 46 Asia Pacific smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 47 Asia Pacific smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 48 Asia Pacific smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 49 Japan smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 50 Japan smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 51 Japan smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 52 Japan smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 53 China smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 54 China smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 55 China smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 56 China smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 57 India smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 58 India smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 59 India smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 60 India smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 61 Australia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 62 Australia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 63 Australia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 64 Australia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)'
- Table 61 South Korea smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 62 South Korea smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 63 South Korea smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 64 South Korea smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 61 Singapore smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 62 Singapore smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 63 Singapore smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 64 Singapore smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 65 Latin America smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
- Table 66 Latin America smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 67 Latin America smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 68 Latin America smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 69 Latin America smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 70 Brazil smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 71 Brazil smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 72 Brazil smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 73 Brazil smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 74 Mexico smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 75 Mexico smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 76 Mexico smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 77 Mexico smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 74 Argentina smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 75 Argentina smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 76 Argentina smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 77 Argentina smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 78 MEA smart inhalers market estimates and forecasts, by country, 2017 - 2030 (USD Million)
- Table 71 MEA smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 72 MEA smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 73 MEA smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 74 MEA smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 75 South Africa smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 76 South Africa smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 77 South Africa smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 78 South Africa smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 75 Saudi Arabia smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 76 Saudi Arabia smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 77 Saudi Arabia smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 78 Saudi Arabia smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
- Table 75 UAE smart inhalers market estimates and forecasts, by type, 2017 - 2030 (USD Million)
- Table 76 UAE smart inhalers market estimates and forecasts, by indication, 2017 - 2030 (USD Million)
- Table 77 UAE smart inhalers market estimates and forecasts, by distribution channel, 2017 - 2030 (USD Million)
- Table 78 UAE smart inhalers market estimates and forecasts, by end-use, 2017 - 2030 (USD Million)
List of Figures
- Fig. 1 Smart inhalers market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value chain based sizing & forecasting
- Fig. 7 QFD modelling for market share assessment
- Fig. 8 Market formulation & validation
- Fig. 9 Smart Inhalers market outlook, 2021 (USD Million)
- Fig. 10 Market trends & outlook
- Fig. 11 Market driver relevance analysis (Current & future impact)
- Fig. 12 Market restraint relevance analysis (Current & future impact)
- Fig. 13 Penetration & growth prospect mapping
- Fig. 14 Smart inhalers type market share analysis, 2022 & 2030 (USD Million)
- Fig. 15 Smart inhalers type market: Segment dashboard
- Fig. 16 Metered dose inhalers (MDIs) market, 2017 - 2030 (USD Million)
- Fig. 17 Dry powdered inhalers (DPIs) market, 2017 - 2030 (USD Million)
- Fig. 18 Smart inhalers indication market share analysis, 2021 & 2030 (USD Million)
- Fig. 19 Smart inhalers indication market: Segment dashboard
- Fig. 20 Asthma market, 2017 - 2030 (USD Million)
- Fig. 21 COPD market, 2017 - 2030 (USD Million)
- Fig. 22 Others market, 2017 - 2030 (USD Million)
- Fig. 23 Smart inhalers distribution channel market share analysis, 2021 & 2030 (USD Million)
- Fig. 24 Smart inhalers distribution channel market: Segment dashboard
- Fig. 25 Hospital pharmacies market, 2017 - 2030 (USD Million)
- Fig. 26 Retail pharmacies market, 2017 - 2030 (USD Million)
- Fig. 27 Online pharmacies market, 2017 - 2030 (USD Million)
- Fig. 28 Smart inhalers end-use market share analysis, 2021 & 2030 (USD Million)
- Fig. 29 Smart inhalers end-use market: Segment dashboard
- Fig. 30 Hospitals market segmentation market, 2017 - 2030 (USD Million)
- Fig. 31 Homecare settings market segmentation market, 2017 - 2030 (USD Million)
- Fig. 32 Smart inhalers regional market share analysis, 2021 & 2030 (USD Million)
- Fig. 33 Regional market place: Key takeaways
- Fig. 34 North America smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 35 U.S. smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 36 Canada smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 37 Europe smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 38 U.K. smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 39 Germany smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 40 France smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 41 Italy smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 42 Spain smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 42 Russia smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 43 Asia Pacific smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 44 Japan smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 45 China smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 46 India smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 46 Australia smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 46 South Korea smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 46 Singapore smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 47 Latin America smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 48 Brazil smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 49 Mexico smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 49 Argentina smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 50 MEA smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 51 South Africa smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 51 Saudi Arabia smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 51 UAE smart inhalers market, 2017 - 2030 (USD Million)
- Fig. 52 Strategy framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.